Fig. 1: Anemia Response in transfusion-dependent and non-transfusion-dependent patients, subdivided by prior exposure to JAKi (graphic version). | Blood Cancer Journal

Fig. 1: Anemia Response in transfusion-dependent and non-transfusion-dependent patients, subdivided by prior exposure to JAKi (graphic version).

From: Real world outcomes of momelotinib in myelofibrosis patients with anemia: results from the MOMGEMFIN study

Fig. 1: Anemia Response in transfusion-dependent and non-transfusion-dependent patients, subdivided by prior exposure to JAKi (graphic version).The alternative text for this image may have been generated using AI.

Patients with prior JAK inhibitor exposure are shown in red, naive patients are depicted in green. *The analysis included patients with anemia per the 2024 IWG-ELN criteria who had at least one month of follow-up for response evaluation. m: months, TDA: Transfusion-Dependent Anemia, JAKi: Janus Kinase Inhibitor.

Back to article page